AMI Co., Ltd. receives regulatory approval for ‘Digital Biomarker DNP-AS’

Last updated: December 29, 2025 12:26 pm

AMI Inc., which is working to make medical innovation faster through AI medical devices and remote medical services, announced that on December 25, 2025, it received pharmaceutical approval for the ‘Digital Biomarker DNP-AS.’ This is a program for general-purpose phonocardiographs that they have been developing for some time.

They plan to keep pushing research and development of medical devices and related services to create a society where anyone can get the best medical care anytime, anywhere.

Also Read: EPARK Dental Brings Patient Communication onto LINE

This milestone was achieved with support from a project funded by the New Energy and Industrial Technology Development Organization, NEDO.

Share This Article

ByITBT StaffWriter

Follow:

ITBT Staffwriter is an in-house contributor at IT Business Today, responsible for delivering timely News and QuickBytes. The author covers the latest developments across IT, tech, and enterprise solutions to keep readers informed with concise and impactful updates.